3.0.0 2074 2022-11-01T13:50:43Z 2022-11-01T13:50:43Z Senate S 2019-07-10 116 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2019-07-10T16:52:02Z Mainstreaming Addiction Treatment Act of 2019 116 2482 HR 2019-05-31 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. Related bill CRS 2019-07-10 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2019-07-10 Introduced in Senate IntroReferral 10000 9 Library of Congress H001076 Sen. Hassan, Margaret Wood [D-NH] Maggie Hassan D NH N M001153 Sen. Murkowski, Lisa [R-AK] Lisa Murkowski R AK 2019-07-10 True S001198 Sen. Sullivan, Dan [R-AK] Dan Sullivan R AK 2019-07-29 False B001267 Sen. Bennet, Michael F. [D-CO] Michael Bennet D CO 2019-09-23 False M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2019-10-16 False H001079 Sen. Hyde-Smith, Cindy [R-MS] Cindy Hyde-Smith R MS 2020-10-25 False Commerce Administrative law and regulatory procedures Crime and Law Enforcement Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Federal preemption Government information and archives Health care coverage and access Health personnel Licensing and registrations Prescription drugs State and local government operations Commerce 00 2019-07-10 Introduced in Senate 2021-02-12T14:02:54Z Mainstreaming Addiction Treatment Act of 2019

This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).

Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity.

The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.

]]> Mainstreaming Addiction Treatment Act of 2019 Display Title Mainstreaming Addiction Treatment Act of 2019 Short Title(s) as Introduced Mainstreaming Addiction Treatment Act of 2019 Introduced in Senate IS Official Title as Introduced A bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes. Introduced in Senate IS Introduced in Senate 2019-07-10T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s2074is/xml/BILLS-116s2074is.xml 2019-07-10 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.